Literature DB >> 2107558

5-HT1C receptors in the serotonergic control of periaqueductal gray induced aversion in rats.

F Jenck1, C L Broekkamp, A M Van Delft.   

Abstract

The functional role of brain 5-HT and 5-HT receptor subtypes in periaqueductal gray (PAG) induced aversion has been investigated in rats. Antiaversive effects were found with the serotonin agonists TFMPP, mCPP and DOI but not with RU 24969 which was found to facilitate PAG aversion. The first three serotonin agonists share potent 5-HT1C activity while RU 24969 differs with a high 5-HT1A activity. Proaversive effects were found with the mixed 5-HT1C/5-HT2 antagonists cyproheptadine and ritanserin; this effect was already reported for the mixed 5-HT1C/5-HT2 antagonists metergoline and mianserin and is opposite to the effects of the selective 5-HT2 antagonists ketanserin, pirenperone, trazodone and spiperone. The antiaversive effects of mCPP (1 mg/kg) could be prevented by pretreatment of the animals with mianserin (1 and 10 mg/kg). These results suggest that 5-HT1C receptors play an important role in the serotonergic control of PAG aversion. 5-HT1C receptor activation seems to mediate antiaversive effects whereas acute 5-HT1C receptor blockade appears to facilitate PAG aversion. Functional interactions take place between several receptor types in the in vivo control of PAG aversion, where 5-HT1C receptors appear to play a predominant function.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2107558     DOI: 10.1007/bf02244609

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Modulation of the brain aversive system by GABAergic and serotonergic mechanisms.

Authors:  F G Graeff; M L Brandão; E A Audi; M T Schütz
Journal:  Behav Brain Res       Date:  1986-11       Impact factor: 3.332

2.  Serotonergic reduction of dorsal central gray area stimulation-produced aversion.

Authors:  R S Kiser; D C German; R M Lebovitz
Journal:  Pharmacol Biochem Behav       Date:  1978-07       Impact factor: 3.533

3.  Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.

Authors:  J E Leysen; F Awouters; L Kennis; P M Laduron; J Vandenberk; P A Janssen
Journal:  Life Sci       Date:  1981-03-02       Impact factor: 5.037

4.  Enhancing GABAergic transmission reverses the aversive state in rats induced by electrical stimulation of the periaqueductal grey region.

Authors:  P Bovier; C L Broekkamp; K G Lloyd
Journal:  Brain Res       Date:  1982-09-30       Impact factor: 3.252

5.  Ethyl alcohol on escape from electrical periaqueductal gray stimulation in rats.

Authors:  P Bovier; C L Broekkamp; K G Lloyd
Journal:  Pharmacol Biochem Behav       Date:  1984-09       Impact factor: 3.533

6.  Long-term imipramine treatment enhances locomotor and food intake suppressant effects of m-chlorophenylpiperazine in rats.

Authors:  C S Aulakh; R M Cohen; J L Hill; D L Murphy; J Zohar
Journal:  Br J Pharmacol       Date:  1987-08       Impact factor: 8.739

7.  Comparison of effects of some 5-HT1 agonists on blood pressure and heart rate of normotensive anaesthetized rats.

Authors:  H Dabire; C Cherqui; B Fournier; H Schmitt
Journal:  Eur J Pharmacol       Date:  1987-08-21       Impact factor: 4.432

8.  Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.

Authors:  G A Kennett; G Curzon
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

9.  Role of the periaqueductal gray substance in the antianxiety action of benzodiazepines.

Authors:  L C Schenberg; F G Graeff
Journal:  Pharmacol Biochem Behav       Date:  1978-09       Impact factor: 3.533

10.  Opposite control mediated by central 5-HT1A and non-5-HT1A (5-HT1B or 5-HT1C) receptors on periaqueductal gray aversion.

Authors:  F Jenck; C L Broekkamp; A M Van Delft
Journal:  Eur J Pharmacol       Date:  1989-02-28       Impact factor: 4.432

View more
  4 in total

1.  Involvement of 5-HT1B receptors in the anticonflict effect of m-CPP in rats.

Authors:  E Chojnacka-Wójcik; A Kłodzińska
Journal:  J Neural Transm Gen Sect       Date:  1992

2.  Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.

Authors:  C A Briggs; N J Pollock; D E Frail; C L Paxson; R F Rakowski; C H Kang; J W Kebabian
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

Review 3.  5HT drugs in animal models of anxiety.

Authors:  S L Handley; J W McBlane
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Attenuation of chemically induced defence response by 5-HT1 receptor agonists administered into the periaqueductal gray.

Authors:  S R Beckett; A J Lawrence; C A Marsden; P W Marshall
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.